Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial by Fennell, Dean A, Prof, King, Amy, MSc, Mohammed, Seid, MSc, Greystoke, Alastair, FRCP, Anthony, Sarah, BSc, Poile, Charlotte, PhD, Nusrat, Nada, MD, Scotland, Molly, RN, Bhundia, Vina, BSc, Branson, Amy, BSc, Brookes, Cassandra, MSc, Darlison, Liz, MSc, Dawson, Alan G, MRes, Gaba, Aarti, MSc, Hutka, Margaret, MD, Morgan, Bruno, Prof, Bajaj, Amrita, FRCR, Richards, Cathy, FRCPath, Wells-Jordan, Peter, FIBMS, Thomas, Anne, Prof

Get full text